Telix Pharmaceuticals Limited Amortisation Expense
Telix Pharmaceuticals Limited (TLPPF) reported Amortisation Expense of $9.88 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AmortisationExpense · last filed 2026-02-20
AUD
| Period end | Amortisation Expense 12 month |
|---|---|
| 2024-12-31 | 4.51M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 4.34M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 4.10M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Amortisation Expense 12 month |
|---|---|
| 2025-12-31 | $9.88M 20-F · filed 2026-02-20 |
| 2024-12-31 | $2.54M 20-F · filed 2026-02-20 |
| 2023-12-31 | $2.88M 20-F · filed 2026-02-20 |